SATO PHARMACEUTICAL CO.,LTD.JP:E00954Balance sheet

Market cap
P/E ratio
2013/072014/072015/072016/072017/072018/072019/072020/072021/072022/072023/07
Cash and cash equivalents -21,14625,19225,15821,38522,64124,58224,22025,38125,34725,922
Marketable securities, current -5,4066,0514,0137,4763,7981,5002,0002,0001,1201,500
Accounts receivable, net-12,29112,16313,66812,35813,45715,53814,35516,32417,20817,288
Inventories-3,8203,6683,8984,1414,3915,1577,6906,3186,1407,160
Total current assets-45,70050,69851,15449,51848,11950,44252,37854,14253,96456,319
Property, plant and equipment, net-35,21435,99436,49436,90836,64836,69036,26536,42736,57435,736
Marketable securities, non-current -15,40115,22815,20313,64917,73918,45016,43014,39016,68219,272
Total non-current assets-59,53557,22556,41657,37760,98362,36159,95657,76460,02261,781
Total assets -105,236107,923107,571106,896109,103112,804112,335111,906113,987118,101
Accounts payable-1,9321,9682,6222,3673,0833,1083,2272,1292,7223,675
Total current liabilities-6,4136,7807,3896,9688,50110,7078,2287,2778,58210,647
Total non-current liabilities-10,33211,31711,36111,32911,25211,20211,50511,30311,19710,987
Total liabilities -16,74518,09818,75118,29719,75321,91019,73318,58019,77921,634
Common stock and paid-in capital -2,8972,8972,8972,8972,8972,8972,8972,8972,8972,897
Retained earnings-87,96389,01988,60588,14988,90290,80792,59693,04493,68995,556
Stockholders' equity87,03888,49089,82588,82088,59889,34990,89492,60193,32594,20796,466